Mainstay Medical’s Chronic Low Back Pain Device Approved Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The company plans to launch the product in the first half of 2021. Source: Devices & Diagnostics Letter You Might Also Like Glenmark Pharmaceuticals Gets Indian Approval for Favipiravir as a COVID-19 Treatment June 22, 2020 FDA Lifts Ban on Indian Firm to Facilitate Hydroxychloroquine, Chloroquine Shipments March 24, 2020 Preceptis’ Ear Tube System Receives FDA Clearance June 22, 2020
